PG
AZN icon

PEAK6 Group’s AstraZeneca AZN Stock Holding History

PEAK6 Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$2.07M Sell
29,500
-32,500
-52% -$2.34M 0.01% 1338
2018
Q1 		$4.34M Buy
62,000
+2,150
+4% +$149K 0.02% 884
2017
Q4 		$4.15M Sell
59,850
-64,900
-52% -$4.38M 0.02% 924
2017
Q3 		$8.45M Buy
124,750
+27,550
+28% +$1.74M 0.04% 493
2017
Q2 		$6.63M Sell
97,200
-42,300
-30% -$2.76M 0.04% 566
2017
Q1 		$8.69M Buy
139,500
+115,850
+490% +$6.74M 0.07% 336
2016
Q4 		$1.29M Buy
23,650
+900
+4% +$51.1K 0.01% 1651
2016
Q3 		$1.5M Sell
22,750
-10,300
-31% -$673K 0.01% 1472
2016
Q2 		$2M Sell
33,050
-6,600
-17% -$383K 0.02% 1253
2016
Q1 		$2.23M Sell
39,650
-64,300
-62% -$3.86M 0.02% 1092
2015
Q4 		$7.06M Sell
103,950
-244,700
-70% -$16M 0.05% 533
2015
Q3 		$22.2M Buy
348,650
+188,450
+118% +$12.4M 0.12% 197
2015
Q2 		$10.2M Buy
160,200
+147,400
+1,152% +$10.1M 0.06% 428
2015
Q1 		$876K Sell
12,800
-199,600
-94% -$13.9M 0.01% 2009
2014
Q4 		$14.9M Buy
212,400
+26,800
+14% +$1.92M 0.11% 194
2014
Q3 		$13.3M Buy
185,600
+104,800
+130% +$7.67M 0.1% 226
2014
Q2 		$6M Sell
80,800
-23,700
-23% -$1.71M 0.06% 436
2014
Q1 		$6.78M Buy
104,500
+1,300
+1% +$84K 0.06% 455
2013
Q4 		$6.13M Buy
103,200
+4,000
+4% +$217K 0.04% 591
2013
Q3 		$2.58M Buy
99,200
+40,300
+68% +$2.02M 0.02% 1318
2013
Q2 		$2.79K Buy
+58,900
New +$3M 0.01% 1230

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

PEAK6 Group's AZN Position: Q2 2018 in Review

PEAK6 Group sold out of AstraZeneca (AZN) in Q2 2018, closing a stake of 24,574 shares — an estimated $1.77M sold.

PEAK6 Group first reported a position in AZN in Q1 2014 and held it in 13 quarters. The position peaked at $10.6M in Q3 2015. 530 funds tracked by Wall St. Rank hold AZN as of Q2 2018.

  • PEAK6 Group reported no remaining AstraZeneca position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 24,574 AstraZeneca shares in Q2 2018, an estimated $1.77M.
  • PEAK6 Group first reported a position in AstraZeneca in Q1 2014 and held it in 13 quarters.
  • PEAK6 Group's AstraZeneca position peaked at $10.6M in Q3 2015.
  • 530 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.